Fresenius Medical Care AG News - FMS | ADVFN

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NYSE
Fresenius Medical Care AG (FMS)
Fresenius Medical Care AG (FMS) News

Fresenius Medical Care AG (FMS)

19.69

-0.28

(-1.40%)

Closed July 20 4:00PM

Delayed by 15 minutes

19.70

0.01

(0.05%)

After Hours: 7:59PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

0001333141--12-312021Q22021-06-30false2929794842928765700001333141fms:UnsecuredDebt2013Memberfms:GeneralPartner2Member2013-11-282013-11-280...

Fresenius 2Q Net Income, Sales Grew; Raises Earnings Guidance

By Cecilia Butini Fresenius SE & Co. KGaA said Friday that sales and net income grew in the second quarter, and raised its earnings guidance...

Xenios AG receives approval in China for ECMO devices

Xenios AG, a Fresenius Medical Care company, has received approval from the National Medical Products...

Fresenius Medical Care Supports Education for Healthcare Professionals in Korea With the Opening of Its First Training Center

Offering a wide range of programs and events to help deliver best possible care for chronically and critically...

Specialized Disclosure Report (sd)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K...

Fresenius Medical Care’s International Campaign Recognizes Nurses at the Center of Healthcare

‘Care goes both ways’ campaign demonstrates commitment to Fresenius Medical Care clinical staff on...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Fresenius SE 1Q Sales Fell; Backs 2021 Guidance

By Kim Richters Fresenius SE said sales and adjusted profit in the first quarter declined, and the German healthcare company backed its full-year...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

QuickLinks -- Click here to rapidly navigate through this document SECURITIES AND...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM&n...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6...

Attorneys Investigating Dialysis Company Over Treatment Disruptions, Medical Complications During February Arctic Blast in Te...

Attorneys Investigating Dialysis Company Over Treatment Disruptions, Medical Complications During February Arctic Blast in Texas Reports surface...

mm41

mm41 3 years ago

here my real depot...

Grandmasim

Grandmasim 3 years ago

Roger that. 100% agree....

mm41

mm41 3 years ago

Fresenius is the cheapest bluechip stocks on the market DAX/Germany..My target for Fresenius Company € 52 in the next 3 month

ValueInvestor15

ValueInvestor15 8 years ago

JPMorgan Chase reiterated Fresenius Medical Care (NYSE:FMS) at Buy. Shares currently have 20% upside:

Top Wall Street Ratings

Fresenius Medical Care

Vontobel Financial Produ...

Vontobel Financial Produ...

WisdomTree Multi Asset I...

Exchange Traded Fund Inv...

Integrated System Credit...

BNP Paribas Issuance

Lite Access Technologies

Delayed Upgrade Clock